Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situations
Possibilities of antithrombotic therapy in prevention of cardioembolic stroke (CES) in patients with nonvalvular atrial fibrillation (AF) were significantly broadened after new oral anticoagulants (NOC) have been designed and launched into clinical practice (rivaroxaban being one of these agents). I...
שמור ב:
| Principais autores: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Russo |
| יצא לאור: |
IMA-PRESS LLC
2014-05-01
|
| סדרה: | Неврология, нейропсихиатрия, психосоматика |
| נושאים: | |
| גישה מקוונת: | https://nnp.ima-press.net/nnp/article/view/373 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|